Implementation of the NICE guidelines for primary prevention ICDs is unlikely to cause an unmanageable increase in electrophysiology workload in UK centres.
Projected modest EP workload rise from NICE ICD guidelines appears manageable in UK centres; leaves open prospective confirmation of real-world effects.
It is now well established that the implantable cardioverter-defibrillator (ICD) is the most effective treatment for the primary prevention of life threatening ventricular arrhythmia.1 2 Despite this, its widespread use in the UK for this indication has been minimal, at least in part because of perceived resource implications. In September 2000, the National Institute for Clinical Excellence (NICE) recommended electrophysiological testing (EPS) for all patients with a history of myocardial infarction who have an ejection fraction of less than 35% and three or more beats of non-sustained ventricular tachycardia (NSVT) on a 24 hour Holter monitor. NICE further recommended that all patients in whom a significant ventricular arrhythmia is induced at EPS should have an ICD implanted. The potential effect of the NICE guidelines on workload in UK electrophysiology centres has not been evaluated. UK-HEART examined the utility of …
No takes yet. Share an insight, caveat, or question.
Nicholas Gall (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: